News | Page 2

Daily news and information for physicians in a range of specialties and practice settings.
A team from Johns Hopkins assessed pediatric patients in Baltimore—an area with severe rates of asthma, indoor air pollution, and poor diets.
Christopher Sorli, MD, vice president of medical affairs at Sanofi, discusses the results of a recent trial examining insulin glargine plus lixisenatide. 
After Janssen's submission of an sNDA in March, results of the CREDENCE subgroup analyses were among the most anticipated presentations at ADA 2019. 
A study presented at ADA 2019 examined the efficacy of sitagliptin compared with dapagliflozin in t2d patients 65 years old and older. 
A three-arm clinical trial of the SAMBA program showed that screening for and tailoring to individuals' asthma needs improves their condition management.
A new study of long-term data demonstrates that infliximab and golimumab are both effective, safe treatments for symptoms of ankylosing spondylitis.
FDA has announced the approval of liraglutide injections for treatment of type 2 diabetes among pediatric patients. 
Interim results at 24 weeks show that 75.3% of patients treated with tildrakizumab achieved a 20% improvement compared to 50.6% with placebo.
A 6-month study examining the effects of hepatic-directed prandial insulin in patients with type 1 diabetes mellitus was presented at ADA 2019. 
The new approval allows for easier access to MRIs and direct audio streaming from Android devices.
Copyright© MD Magazine 2006-2019 Intellisphere, LLC. All Rights Reserved.